Windtree Therapeutics Inc
WINT· OTC
Filed Nov 19, 2025 · 10-Q · 50 days after period end · 0001437749-25-035751
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Net Income | -$28.09M | -$2.75M | -$4.43M | -$4.06M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Windtree Therapeutics Inc · CIK 946486 · Engraved from SEC EDGAR
ended Sep 30, 2025 · filed Nov 19, 2025 · 50 d after period end